In the critically ill patient, severe physiological and biochemical imbalances significantly reduce the body's anti-oxidant capacity, disrupting the redox balance [1] . A series of biomarkers are in use, designed to quantify oxidative stress. These comprise interleukin 1 beta, interleukin 6, interleukin 10, tumor necrosis alpha, components of the complement, plasmatic levels of antioxidant enzymes and the microRNA species [2] .
Oxidative stress in the polytrauma patient is produced shortly after the initial trauma. Subsequently, it transfers from the macroscopic level to the cellular level and thereafter to the molecular level. At this level, the oxidative stress is enhanced and self-sustained, generating a second wave of injury which is then responsible for a systemic inflammatory response syndrome (SIRS) and for the excessive biosynthesis of free radicals.
In the critically ill patient with multiple traumas, these events are manifest by the patient becoming vulnerable to microbial grafting. The multiplication of pathogenic germs, immunosuppression and increased levels of pro-inflammatory molecules frequently leads to sepsis and despite intensive treatment, progresses to multiple organ dysfunction syndrome (MODS) and death.
The implications of the oxidative stress in the critically ill polytrauma patient has been the subject of a number of recent reports. Hohl reported a statistically significant correlation between plasma levels of specific biomarkers for oxidative injury with a number of clinical variables, in their study on oxidative stress in patients with traumatic brain injury [3] .
Nathens [4] , in a similar study, reported a series of statistically significant correlations regarding oxidative stress in patients with pulmonary trauma. Moreover, the reduction of a systemic inflammatory response in these patients, following the administration of substances with high anti-oxidant capacity, was highlighted in these studies.
A high percentage of the patients with multiple trauma present with haemorrhagic shock as a consequence of centralisation of the circulation in order to protect vital organs. Blockage in the micro-circulation ensues, followed by tissue hypo-oxygenation in organs with reduced blood flow [5] [6] [7] [8] . Simultaneously, a systemic inflammatory response syndrome is triggered, modulated by trauma intensity and the genetic predisposition of each individual patient [9, 10] .
Crime [11] highlighted the decrease in required time on a mechanical ventilation and in mortality rates, in critically ill patients with multiple trauma who have Available online at: www.jccm.ro received intravenous vitamin C [500 mg/day] and 400 IU/day of Vitamin E. Collier [12] also reported the importance of implementing anti-oxidant therapy in the critically ill patient.
The overall conclusion derived from these studies is that the antioxidant therapy most used in intensive care units consists of Vitamin C, Vitamin E, Vitamin B6, Vitamin B12, Resveratrol and N-Acetylcysteine in various ratios and concentrations, and that the administration of these drugs, to the critically ill polytrauma patient, results in a decrease in the mortality rate and in the length of stay both in an intensive care unit and a hospital [13] .
In this issue, implications of oxidative stress in the critically ill patient with severe head injury are presented in an article by Luca and its research group [14] , following numerous publications on the subject [15, 16] .
In spite of the interesting and important results reported on the beneficial effects of administration of substances with high antioxidant capacity in instances of oxidative stress, the reader is reminded that there are other studies that do not highlight any changes in the clinical development of the critically ill polytrauma patient under similar drug regimes, indicative of the need for further studies in this area.
